Kiniksa Pharmaceuticals International, plc
KNSA
$76.75
-$1.08-1.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.57% | 59.11% | -22.98% | 3.38% | 108.83% |
| Total Depreciation and Amortization | 0.85% | 0.21% | 21.61% | 7.26% | 3.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.31% | 25.97% | -15.89% | 37.26% | -2.32% |
| Change in Net Operating Assets | -43.13% | -60.12% | 2,644.25% | 38.96% | -204.19% |
| Cash from Operations | -5.98% | -6.86% | 60.03% | 19.89% | 25.83% |
| Capital Expenditure | -311.80% | 74.57% | 5.66% | -306.67% | -66.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -129.62% | 54.75% | -13.04% | -1,569.82% | 92.77% |
| Cash from Investing | -130.54% | 54.93% | -12.84% | -1,516.15% | 92.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 175.13% | -25.50% | -47.23% | 27.52% | 300.79% |
| Repurchase of Common Stock | -1,630.38% | 65.58% | 78.91% | -112.65% | -396.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 99.41% | -20.70% | -35.64% | 11.23% | 286.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.61% | 362.97% | 46.09% | -149.22% | 231.97% |